Sign In
Buy JAZZ
$230.93
+4.81 (+2.13%)
At Close: Jun 03, 2026
Jazz Pharmaceuticals Announces Appointment Of Kim Sablich As Executive Vice President, General Manager Of North America
12:30pm, Monday, 11'th May 2020
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Kim Sablich as executive vice president, general manager of North America, effective June 1, 2020. In this role, Ms. Sablich
Why Jazz Pharmaceuticals' Symphony of Growth Is About to End
12:10pm, Saturday, 09'th May 2020
Competition is about to ramp up significantly in the $1.7 billion market for treating chronic sleep disorder.
Edited Transcript of JAZZ earnings conference call or presentation 5-May-20 8:30pm GMT
05:11am, Friday, 08'th May 2020
Q1 2020 Jazz Pharmaceuticals PLC Earnings Call
SunTrust Robinson Humphrey Maintains Buy on Jazz Pharmaceuticals, Lowers Price Target of $153
04:02pm, Wednesday, 06'th May 2020Jazz Pharma (JAZZ) Misses on Q1 Earnings & Sales, Cuts View
03:39pm, Wednesday, 06'th May 2020
Jazz Pharmaceuticals (JAZZ) reports lower-than-expected first-quarter 2020 earnings and revenues. It lowers its guidance for 2020. Shares drop.
BMO Capital Maintains Outperform on Jazz Pharmaceuticals, Lowers Price Target to $193
03:28pm, Wednesday, 06'th May 2020SVB Leerink Maintains Outperform on Jazz Pharmaceuticals, Lowers Price Target to $160
02:53pm, Wednesday, 06'th May 2020Jazz Reports Mixed Q1 but Xyrem Growth Stays Strong; Lowering FVE to $130 From Virus Impact to Sales
02:19pm, Wednesday, 06'th May 2020Jazz Pharmaceuticals (JAZZ) Q1 2020 Earnings Call Transcript
11:04am, Wednesday, 06'th May 2020
JAZZ earnings call for the period ending March 31, 2020.
Why Jazz Pharmaceuticals Sang Off-Key in Q1
11:00am, Wednesday, 06'th May 2020
Jazz Pharmaceuticals (NASDAQ: JAZZ) ended 2019 on a positive note, with shares up 20%. Jazz stock is down more than 30%, wiping out all of the 2019 gains and then some. Here's why Jazz sang off-key
Edited Transcript of JAZZ earnings conference call or presentation 5-May-20 8:30pm GMT
06:29am, Wednesday, 06'th May 2020
Q1 2020 Jazz Pharmaceuticals PLC Earnings Call
The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle
12:00am, Wednesday, 06'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peak
(Biotech Stocks Hitting 52-week Highs May 5)
• Adverum Biotechnologies...
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Lag Estimates
10:45pm, Tuesday, 05'th May 2020
Jazz (JAZZ) delivered earnings and revenue surprises of -31.82% and -0.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
